Xtant Medical Holdings (XTNT) Research & Development (2016 - 2025)
Historic Research & Development for Xtant Medical Holdings (XTNT) over the last 13 years, with Q3 2025 value amounting to $634000.0.
- Xtant Medical Holdings' Research & Development fell 955.78% to $634000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 810.7%. This contributed to the annual value of $2.4 million for FY2024, which is 7851.8% up from last year.
- Latest data reveals that Xtant Medical Holdings reported Research & Development of $634000.0 as of Q3 2025, which was down 955.78% from $566000.0 recorded in Q2 2025.
- In the past 5 years, Xtant Medical Holdings' Research & Development ranged from a high of $701000.0 in Q3 2024 and a low of $151000.0 during Q4 2021
- Its 5-year average for Research & Development is $376315.8, with a median of $262000.0 in 2021.
- As far as peak fluctuations go, Xtant Medical Holdings' Research & Development crashed by 2531.12% in 2023, and later soared by 25333.33% in 2024.
- Over the past 5 years, Xtant Medical Holdings' Research & Development (Quarter) stood at $151000.0 in 2021, then skyrocketed by 53.64% to $232000.0 in 2022, then surged by 112.07% to $492000.0 in 2023, then grew by 6.1% to $522000.0 in 2024, then increased by 21.46% to $634000.0 in 2025.
- Its Research & Development was $634000.0 in Q3 2025, compared to $566000.0 in Q2 2025 and $443000.0 in Q1 2025.